Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Balkrishnan

Showing results (91-100 of 320) with videos related to

Pageof 32
Sort By:
Dermatologic Therapy|June 1, 2007
Does cost-effectiveness play a role in clinical trials?Tace Steele, Manjiri Pawaskar, Rajesh Balkrishnan, et al.
Archives of Dermatology|June 22, 2005
Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers' compensation analysis of Oregon, 1990-1997Brian P McCall, Irwin B Horwitz, Steven R Feldman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 12, 2010
Racial/ethnic disparities in emergency department waiting time for stroke patients in the United StatesSudeep J Karve, Rajesh Balkrishnan, Yousef M Mohammad, et al.
Journal of Glaucoma|September 18, 2007
Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucomaSujata S Jayawant, Monali J Bhosle, Roger T Anderson, et al.
Journal of Medical Economics|September 26, 2013
Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costsSteven R Feldman, Eugenia Levi, Prathamesh Pathak, et al.
The Journal of Dermatological Treatment|February 15, 2008
The pharmacoeconomics of acne treatment: where are we heading?Marc J Inglese, Alan B Fleischer, Steven R Feldman, et al.
Journal of Managed Care & Specialty Pharmacy|June 26, 2020
Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A CommentaryAram Babcock, Askal Ayalew Ali, Rajesh Balkrishnan, et al.
The Journal of Dermatological Treatment|January 25, 2011
Medication use and associated health care outcomes and costs for patients with psoriasis in the United StatesHsien-Chang Lin, Pedro T Lucas, Steven R Feldman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Outcomes associated with inhaled corticosteroid use in asthma and COPD: an updateMonali J Bhosle, Rahul A Shenolikar, Amit S Kulkarni, et al.
Journal of the American Academy of Dermatology|September 27, 2003
Electronic monitoring of medication adherence in skin disease: results of a pilot studyRajesh Balkrishnan, Christie L Carroll, Fabian T Camacho, et al.
Pageof 32

Showing results (91-100 of 320) with videos related to

Sort By:
Pageof 32
Dermatologic Therapy|June 1, 2007
Does cost-effectiveness play a role in clinical trials?Tace Steele, Manjiri Pawaskar, Rajesh Balkrishnan, et al.
Archives of Dermatology|June 22, 2005
Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers' compensation analysis of Oregon, 1990-1997Brian P McCall, Irwin B Horwitz, Steven R Feldman, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 12, 2010
Racial/ethnic disparities in emergency department waiting time for stroke patients in the United StatesSudeep J Karve, Rajesh Balkrishnan, Yousef M Mohammad, et al.
Journal of Glaucoma|September 18, 2007
Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucomaSujata S Jayawant, Monali J Bhosle, Roger T Anderson, et al.
Journal of Medical Economics|September 26, 2013
Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costsSteven R Feldman, Eugenia Levi, Prathamesh Pathak, et al.
The Journal of Dermatological Treatment|February 15, 2008
The pharmacoeconomics of acne treatment: where are we heading?Marc J Inglese, Alan B Fleischer, Steven R Feldman, et al.
Journal of Managed Care & Specialty Pharmacy|June 26, 2020
Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A CommentaryAram Babcock, Askal Ayalew Ali, Rajesh Balkrishnan, et al.
The Journal of Dermatological Treatment|January 25, 2011
Medication use and associated health care outcomes and costs for patients with psoriasis in the United StatesHsien-Chang Lin, Pedro T Lucas, Steven R Feldman, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Outcomes associated with inhaled corticosteroid use in asthma and COPD: an updateMonali J Bhosle, Rahul A Shenolikar, Amit S Kulkarni, et al.
Journal of the American Academy of Dermatology|September 27, 2003
Electronic monitoring of medication adherence in skin disease: results of a pilot studyRajesh Balkrishnan, Christie L Carroll, Fabian T Camacho, et al.
Pageof 32